New York Presbyterian Hospital (Cornell Campus) Dermatology

Topics

• Psoriasis: Treatment and Pathogenesis 647
• Cutaneous Melanoma Detection and Management 632
• Dermatology and Skin Diseases 463
• Nonmelanoma Skin Cancer Studies 281
• Nail Diseases and Treatments 277
• Hair Growth and Disorders 199
• Dermatologic Treatments and Research 168
• Skin Protection and Aging 165
• Hidradenitis Suppurativa and Treatments 155
• Cutaneous lymphoproliferative disorders research 153
• Acne and Rosacea Treatments and Effects 143
• Wound Healing and Treatments 136

Most cited

1. Atopic dermatitis.

   Lancet (London, England) · 2025 · 233 citations · Emma Guttman

2. Diabetic Wound-Healing Science.

   Medicina (Kaunas, Lithuania) · 2021 · 646 citations · Robert Kirsner

3. Breakthrough treatments for accelerated wound healing.

   Science advances · 2023 · 301 citations · Brian Hibler

4. Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.

   Lancet (London, England) · 2023 · 258 citations · Alice Gottlieb

5. Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).

   The British journal of dermatology · 2021 · 502 citations · Emma Guttman

6. Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.

   The New England journal of medicine · 2023 · 275 citations · Emma Guttman

7. Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.